Publications by authors named "Jason G D Gall"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

301,602

Total Likes

3,030

Extended Reach

301,838

Social Features

4
M
Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells.
Cheng Cheng, Jason G D Gall, Wing-pui Kong, Rebecca L Sheets, Phillip L Gomez, C Richter King, Gary J Nabel

PLoS Pathog· February 2007

Videos about Article: user user user

3 1

View All Article and Social Media Activity
C
Characterization of Flu MOSAIC nanoparticle vaccine candidate using high performance size-exclusion chromatography to support vaccine process development.
Rong Sylvie Yang, Yanhong Yang, Daniel B Gowetski, Yaroslav Tsybovsky, Jason G D Gall

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a mass spectrometry based analytical method to quantify the ratios in hemagglutinin trimers in quadrivalent influenza nanoparticle vaccine - FluMos-v1.
Asif Shajahan, Cindy X Cai, Jeremy Wolff, R Sylvie Yang, Vera B Ivleva, Jason G D Gall

Anal Methods· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical characterization of broadly neutralizing antibody CAP256LS heavy chain clipping during manufacturing development.
Deepika Gollapudi, Erwin Rosales-Zavala, Vera B Ivleva, Yanhong Yang, Yile Li, Jason G D Gall

Biotechnol Prog· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development.
Cheng Cheng, Lingshu Wang, Sung-Youl Ko, Wing-Pui Kong, Stephen D Schmidt, Jason G D Gall

Vaccine· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling.
Kylie M Quinn, Daniel E Zak, Andreia Costa, Ayako Yamamoto, Kathrin Kastenmuller, Jason G D Gall

J Clin Invest· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression.
Matthew J Johnson, Niklas K Björkström, Constantinos Petrovas, Frank Liang, Jason G D Gall

Vaccine· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.
Kylie M Quinn, Andreia Da Costa, Ayako Yamamoto, Dana Berry, Ross W B Lindsay, Jason G D Gall

J Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.
Cheng Cheng, Lingshu Wang, Jason G D Gall, Martha Nason, Richard M Schwartz

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates.
Lukas Flatz, Cheng Cheng, Lingshu Wang, Kathryn E Foulds, Sung-Youl Ko, Jason G D Gall

J Virol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure.
Chih-Jen Wei, Hadi M Yassine, Patrick M McTamney, Jason G D Gall, James R R Whittle

Sci Transl Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity.
Matthew J Johnson, Constantinos Petrovas, Takuya Yamamoto, Ross W B Lindsay, Karin Loré, Jason G D Gall

J Immunol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
William C Adams, Cornelia Gujer, Gerald McInerney, Jason G D Gall, Constantinos Petrovas

Proc Natl Acad Sci U S A· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of human adenovirus 35 and derivation of complex vectors.
Duncan McVey, Mohammed Zuber, Damodar Ettyreddy, Christopher D Reiter, Douglas E Brough, Jason G D Gall

Virol J· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28.
Christoph A Kahl, Jessica Bonnell, Suja Hiriyanna, Megan Fultz, Cassandra Nyberg-Hoffman, Jason G D Gall

Vaccine· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
Ross W B Lindsay, Patricia A Darrah, Kylie M Quinn, Ulrike Wille-Reece, Lisa M Mattei, Jason G D Gall

J Immunol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization.
Cheng Cheng, Jason G D Gall, Martha Nason, C Richter King, Richard A Koup

J Virol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunity.
Lingshu Wang, Cheng Cheng, Sung-Youl Ko, Wing-Pui Kong, Masaru Kanekiyo, Jason G D Gall

J Virol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials.
Richard A Koup, Laurie Lamoreaux, David Zarkowsky, Robert T Bailer, C Richter King, Jason G D Gall

J Virol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.
Sung-Youl Ko, Cheng Cheng, Wing-Pui Kong, Lingshu Wang, Masaru Kanekiyo, Jason G D Gall

J Virol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.
Franck Lemiale, Hedi Haddada, Gary J Nabel, Douglas E Brough, C Richter King, Jason G D Gall

Vaccine· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes.
Jason G D Gall, Alena Lizonova, Damodar EttyReddy, Duncan McVey, Mohammed Zuber

Mol Biotechnol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.
Andrew T Catanzaro, Richard A Koup, Mario Roederer, Robert T Bailer, Mary E Enama, Jason G D Gall

J Infect Dis· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.
John W Schoggins, Jason G D Gall, Erik Falck-Pedersen

J Virol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis